tradingkey.logo
tradingkey.logo
Pesquisar

Prenetics Global Ltd

PRE
Adicionar à lista de desejos
16.930USD
-0.960-5.37%
Fechamento 07/02, 13:00ETCotações atrasadas em 15 min
287.82MValor de mercado
PerdaP/L TTM

Mais detalhes de Prenetics Global Ltd Empresa

Prenetics Global Ltd is a company principally engaged in the provision of diagnostic and preventive products and services. The Company operates its business through two segments. The Diagnostics segment is mainly engaged in the sale of precision oncology testing services. The Prevention segment is mainly engaged in the design and sale of genetics testing, including update services, and stool-based deoxyribonucleic acid (DNA) tests for early colorectal cancer screening. The Company's products and services include CircleDNA, ACTOnco, ACTHRD and other products. The in-house developed consumer genetic testing product, CircleDNA, offers comprehensive DNA tests capitalizing on in-house developed testing algorithm. ACTOnco is a comprehensive cancer test used to guide treatment selection for major solid tumors. ACTHRD is a test for the homologous recombination deficiency status of cancer patients. The Company is also engaged in consumer health products by a new health and wellness brand IM8.

Informações de Prenetics Global Ltd

Código da empresaPRE
Nome da EmpresaPrenetics Global Ltd
Data de listagemJul 06, 2021
CEOKwok (Samantha)
Número de funcionários285
Tipo de títulosOrdinary Share
Fim do ano fiscalJul 06
EndereçoUnit 703-706, K11 Atelier King's Road, 728 King's Road, Quarry Bay
Cidade
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísHong Kong
Código postal- -
Telefone85222109588
Sitehttps://ir.prenetics.com/
Código da empresaPRE
Data de listagemJul 06, 2021
CEOKwok (Samantha)

Executivos da empresa Prenetics Global Ltd

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Sheng Wu (Danny) Yeung
Mr. Sheng Wu (Danny) Yeung
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Mr. Yin Pan (Ben) Cheng
Mr. Yin Pan (Ben) Cheng
Independent Director
Independent Director
--
--
Ms. Wing Kwan (Winnie) Chiu
Ms. Wing Kwan (Winnie) Chiu
Independent Director
Independent Director
--
--
Dr. Chi Hung (Lawrence) Tzang, Ph.D.
Dr. Chi Hung (Lawrence) Tzang, Ph.D.
Co-Founder, Chief Scientific Officer
Co-Founder, Chief Scientific Officer
--
--
Mr. Hoi Chun (Stephen) Lo
Mr. Hoi Chun (Stephen) Lo
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Senthil Sundaram, M.D.
Dr. Senthil Sundaram, M.D.
Chief Clinical Officer
Chief Clinical Officer
--
--
Dr. Yung Ho (Peter) Wong
Dr. Yung Ho (Peter) Wong
Chief Technology Officer
Chief Technology Officer
--
--
Mr. Joel Neoh
Mr. Joel Neoh
Chief Consumer Officer, Chief Executive Officer of CircleDNA
Chief Consumer Officer, Chief Executive Officer of CircleDNA
--
--
Ms. Kathryn Henry
Ms. Kathryn Henry
Independent Director
Independent Director
--
--
Mr. David Vanderveen
Mr. David Vanderveen
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Sheng Wu (Danny) Yeung
Mr. Sheng Wu (Danny) Yeung
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Mr. Yin Pan (Ben) Cheng
Mr. Yin Pan (Ben) Cheng
Independent Director
Independent Director
--
--
Ms. Wing Kwan (Winnie) Chiu
Ms. Wing Kwan (Winnie) Chiu
Independent Director
Independent Director
--
--
Dr. Chi Hung (Lawrence) Tzang, Ph.D.
Dr. Chi Hung (Lawrence) Tzang, Ph.D.
Co-Founder, Chief Scientific Officer
Co-Founder, Chief Scientific Officer
--
--
Mr. Hoi Chun (Stephen) Lo
Mr. Hoi Chun (Stephen) Lo
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Senthil Sundaram, M.D.
Dr. Senthil Sundaram, M.D.
Chief Clinical Officer
Chief Clinical Officer
--
--

Perguntas frequentes

Quem são os cinco principais acionistas de Prenetics Global Ltd?

Os cinco principais acionistas de Prenetics Global Ltd são: Mr. Sheng Wu (Danny) Yeung

Quantas instituições possuem ações da Prenetics Global Ltd (PRE)?

Em 2026Q1, 46 instituições possuíam ações da Prenetics Global Ltd, com valor de mercado aproximado de 1.76M, representando 11.33% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -778478.00.